Protect Your Portfolio Against Market Uncertainty
- Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
- Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
Innovotech ( (TSE:IOT) ) has issued an announcement.
Innovotech Inc. announced that its subsidiary, Innovotech Labs Corporation, has secured up to $150,000 CAD in funding from the NRC IRAP to develop new antimicrobial testing services for medical devices, aligning with changing international standards. Additionally, the company will receive $30,000 CAD to hire a young graduate for developing antimicrobial silver compounds. This support is expected to enhance Innovotech’s technical capabilities, address customer needs, and improve health outcomes by reducing infections and complications.
More about Innovotech
Innovotech Inc. is a diversified Canadian technology company involved in specialized laboratory services, biotechnology, and proprietary intellectual property. It operates through subsidiaries like Innovotech Labs Corporation, which provides antimicrobial testing devices and solutions, and Keystone Labs Inc., serving the pharmaceutical and industrial markets. Innovotech also holds a stake in NouLife Sciences Inc., focusing on antioxidant molecules for cosmetics and medical applications.
Average Trading Volume: 23,549
Technical Sentiment Signal: Sell
Current Market Cap: C$7.21M
Find detailed analytics on IOT stock on TipRanks’ Stock Analysis page.